Powder Delivery TRIZ Cases

Freeze-dried FGF-18 formulations with poloxamer 188 and sucrose prevent protein denaturation, ensuring stability at room temperature for up to 24 months.

Rod-shaped polydixylitol nanochains penetrate the blood-brain barrier via osmotic pressure, suppressing brain tumor growth without invasive procedures.

Porous calcium phosphate particles adsorb minocycline to provide sustained release, reducing systemic side effects from oral administration.

Cyclic compounds constrain A-beta sequences to create conformational epitopes, enabling antibodies to selectively bind toxic oligomers over monomers.

Titration precipitates micronized insulin particles at room temperature, avoiding heat-induced aggregation and polymer impurities.

Peptide amphiphile nanofibers deliver stable VEGF mimetics, overcoming the short half-life and immunogenicity of recombinant therapies.

Optimized emulsion formulations reduce triglyceride levels by increasing oral bioavailability and lowering administration burden.

Conjugating hydrophobic nanoparticles with liver targeting moieties delivers thyroid receptor beta1 agonists to hepatic tissue, reducing systemic side effects.

Mechanically disintegrated nanofibrillated cellulose forms a tight fiber network for sustained bioactive agent release.

Amine-based cationic lipids form lipid nanoparticles that absorb polyanionic payloads, overcoming cell membrane barriers to enable efficient gene silencing.

Metal catalyst nanoparticles drive exponential redox reactions to overcome insufficient sensitivity in low concentration analyte quantification.

Sugars and glycine derivatives protect aluminium salt adjuvants from structural damage during freeze-drying, maintaining vaccine immunogenicity.

Transitioning platelets to a dry state with activation inhibitors extends shelf-life while preserving function lost in liquid storage.

Hierarchical zeolites adsorb turmeric via secondary porosity, resolving poor bioavailability and insufficient prolonged release in conventional carriers.

Pervaporation concentrates crude allergen extracts while pH adjustment prevents precipitation, enabling high-yield production of stable intermediates.

Detonation synthesis nanodiamonds suspended in Siberian Sea Buckthorn Berry Oil accelerate wound closure through catalytic and adsorptive surface interactions.

Hot-melt extrusion creates an amorphous solid dispersion that prevents moisture-induced degradation and improves compressibility.

Segmented bifunctional ligands merge fast kinetics with in vivo stability, resolving slow complexation trade-offs.

Segmented magnetic nanoparticles enable selective drug delivery to multiple organs by tuning resonance frequencies, reducing toxicity risks.

Inhaled chitinase breaks down accumulated chitin polymers, resolving inflammation and treating pulmonary fibrosis.

Non-volatile ester stabilizers prevent glyceryl trinitrate volatilization in solid granules, ensuring storage stability and rapid onset of action.

A solid mixture of alginic acid, bicarbonate salts, and simethicone neutralizes gastric acid reflux to protect mucosal tissues.

Quinoline derivative formulations combined with anti-viral agents lower viral loads to prevent severe respiratory infections.

Photon-emitting phosphors convert penetrating X-rays into visible light to activate photoactivatable drugs within deep tissue.

A pharmaceutical composition increases microRNA-26a levels in skin-derived exosomes to promote myogenesis.

Segmenting ceftolozane and tazobactam into separate containers prevents impurity formation, maintaining pharmaceutical stability and extending shelf-life.

Optimized antibody formulations with trehalose and histidine buffer maintain stability at high concentrations while targeting toxic amyloid deposits.

Multi-specific VHH antibodies enhance binding affinity and neutralize SARS-CoV-2 while simplifying production complexity.

A cannabinoid pouch uses a water-soluble powdered matrix to deliver active ingredients through the oral mucosa.

Buffered polyhydric alcohol gels stabilize nitric oxide release, reducing inflammatory lesions and P. acnes counts within four weeks.

Functionalized nanoparticles activate complement systems to target antigen presenting cells in lymph nodes.

Modified HIV-1 gp140 proteins utilize HR1 loop sequences and engineered disulfide bonds to enhance trimer stability.

Nanoparticles ferry therapeutic agents across the blood-brain barrier via receptor-mediated transcytosis, overcoming impermeability to reach brain tissue.

Spray-congealed mannitol carriers improve flowability and respirable fraction by eliminating fine excipients that cause agglomeration.

Replacing sodium citrate with a PEG-polylysine graft copolymer prevents aggregation at high concentrations while maintaining biocompatibility.

Molecularly imprinted polymer nanoparticles replace toxic antibodies, providing specific in vivo diagnostics without immunologic responses.

Recombinant RNA molecules with chemical modifications deliver therapeutic proteins to promote wound healing.

A biodegradable particle sealant permeates tumor vessels and swells to form a gel barrier that starves cancer cells.

Refined Coix seed oil containing 11 triglycerides via supercritical extraction and alumina purification.

Macroparticle formulation prevents dust contamination and maintains adsorptive capacity during rectal administration.

A thermokinetic mixer adjusts shaft speed during continuous rotation to blend ingredients while managing shear energy delivery.

Intrathecal arylsulfatase A delivery bypasses the blood-brain barrier to treat lysosomal storage diseases.

Crosslinked degradable nanoparticles solve reproducibility issues in particle size and shape while enabling targeted drug delivery.

Modular polymeric artificial antigen-presenting cells resolve isolation complexity by providing a ready-to-use platform for tunable T cell stimulation.

A liposome composition encapsulates ten essential oils to provide sustained release of active ingredients.

Optimized sucroferric oxyhydroxide particle size distribution enables direct compression into stable compressed tablets.

Arginine, citrate, sucrose, and mannitol in a lyophilized factor Xa antidote formulation resolve storage stability versus post-process solubility trade-offs.

Antioxidant additives in NODAGA-peptide formulations prevent radiolysis degradation, extending shelf-life to three months before radiolabeling.